🇺🇸 FDA
Patent

US 11919915

Compounds and methods useful for stabilizing phenylalanine hydroxylase mutations

granted A61KA61K31/437A61K31/4709

Quick answer

US patent 11919915 (Compounds and methods useful for stabilizing phenylalanine hydroxylase mutations) held by Agios Pharmaceuticals, Inc. expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Agios Pharmaceuticals, Inc.
Grant date
Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
30
CPC classes
A61K, A61K31/437, A61K31/4709, A61K31/4725, A61K31/496